ENZN - Enzon Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue8,37717,45631,173
Cost of Revenue---
Gross Profit8,37717,45631,173
Operating Expenses
Research Development---
Selling General and Administrative1,7336,6562,383
Non Recurring---
Total Operating Expenses---
Operating Income or Loss6,64410,80028,790
Income from Continuing Operations
Total Other Income/Expenses Net--61
Earnings Before Interest and Taxes6,64410,80028,851
Interest Expense---
Income Before Tax6,64410,80028,851
Income Tax Expense7,770-10,83756
Minority Interest---
Net Income From Continuing Ops-1,12621,63728,795
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,12621,63728,795
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,12621,63728,795